Tagged Articles

lawsuit 2137 articles

Plaintiffs identify Philadelphia woman as model case for Zimmer knee implant lawsuit

Zimmer knee

Plaintiffs in a multidistrict litigation involving alleged defects with Zimmer knee implants asked an Illinois federal judge to select the case of a Philadelphia woman to serve as the first bellwether trial, claiming that the woman’s age, gender and implant type best represent plaintiffs’ issues with the implants. Ramona Diano, 72, had Zimmer LPS Flex Gender femoral components implanted in both knees. Both implants failed. Plaintiffs say that Diano is in the most common age group and gender for the procedure, and her case has the least individual issues among the other cases previously identified as possible bellwethers. Dinao’s lawsuit ... Read More

Bellwether cases soon to be selected for Mentor Corp transvaginal mesh


A Georgia federal judge identified six possible bellwether cases out of hundreds accusing Johnson & Johnson unit Mentor Corp of not informing patients or doctors of the risks associated with its ObTape sling transvaginal mesh device used to treat urinary incontinence in women. U.S. District Judge Clay D. Land ordered the parties to select two of the six lawsuits within three weeks. The cases will be tried in October and November 2015. The lawsuits allege Mentor marketed the defective devices, which caused serious injuries to women. Mentor discontinued the implants in 2006. Transvaginal mesh is used to treat pelvic organ ... Read More

Judge rules $2 million verdict stands against transvaginal mesh maker

bladder sling

A federal judge denied a mistrial and left intact a $2 million jury verdict against medical device manufacturer C. R. Bard Inc., in a bellwether trial over claims that its transvaginal mesh implant was defective and caused serious injuries. U.S. District Judge Joseph R. Goodwin said the motion stood because the company had not proven a miscarriage of justice. However, Goodwin also did not find unconstitutional a provision in Georgia’s Tort Reform Act of 1987 that requires product liability plaintiffs to give up 75 percent of their punitive damage earnings to the state. This comes as a blow to plaintiffs Donna and ... Read More

Most Medicare recipients not filling statin prescriptions after heart-related hospitalization


The majority of Medicare beneficiaries do not fill prescriptions for high-intensity statin drugs after being hospitalized for complications related to coronary heart disease, a new study has found. Researchers with the Icahn School of Medicine at Mount Sinai in New York City examined the proportion of Medicare recipients filing statin prescriptions after being discharged from the hospital for a cardiac event. They found that only 27 percent of first post-discharge prescription fills among 8,762 Medicare beneficiaries filling a statin prescription after a cardiovascular event were for a high-intensity statin. Cholesterol-lowering statins are prescribed to help prevent heart attacks and strokes ... Read More

Fund requested to manage awards paid to women injured by transvaginal mesh

bladder sling

Women from more than 100 lawsuits in a multidistrict litigation (MDL) alleging injuries caused by Johnson & Johnson unit Mentor Corp.’s defective transvaginal mesh implant asked a Georgia federal judge this week to approve the establishment of a settlement fund trust to resolve their claims. The qualified settlement fund trust would hold, manage and distribute funds in the account under the settlements reached in April for 111 lawsuits in the multidistrict litigation. The trust would also cover additional lawsuits as they resolve. Both the settlements and the total amount in the trust are confidential. The lawsuits allege that Mentor Corp.’s ... Read More

Johnson and Johnson wants victims of transvaginal mesh to prove their injuries

bladder sling

Johnson & Johnson wants women in a multidistrict litigation alleging defects with the company’s transvaginal mesh device to prove they were injured by the mesh or that they even have the device in the first place. Attorneys for Johnson & Johnson claim that people from fictitious firms are calling women often repeatedly to join the lawsuit against the company in order to reap tens of thousands of dollars in compensation. In some cases, Johnson & Johnson claims, women are being told to lie and say they have been injured by the mesh even if they have never been implanted with ... Read More

First-time users of testosterone replacement treatments are at greater risk of heart attack

Low T

Men using testosterone replacement treatments are at greater risk of suffering a heart attack during the first 90 days of treatment than men who have been on the hormone replacement for more than four months. They were also at greater risk of heart attack compared to men who had used the treatment and discontinued use, according to a new study published in the journal Pharmacotherapy. The study involved data from the IMS LikeLink database for new-onset heart attacks in men ages 45 to 80 who had filled at least one prescription for testosterone replacement therapy. Researchers looked at current users ... Read More

New adverse events listed on safety label of Xarelto blood thinner


The safety label for the new blood thinner Xarelto (rivaroxaban) has been updated to include a new adverse reaction for thrombocytopenia, a condition associated with abnormal bleeding, as well as hepatitis and other liver injuries. Xarelto blood thinner, made by Johnson & Johnson unit Janssen Pharmaceuticals and Bayer, is an anticoagulant used to treat or prevent blood clots in some heart patients and patients undergoing knee or hip replacement surgery. It is in a new class of blood thinners known as Xa Inhibitors, which also includes the brand name drugs Pradaxa and Eliquis. This class of drugs is the first ... Read More

FDA requests more safety data on experimental testosterone treatment after adverse event reported

Low T

The Food and Drug Administration (FDA) is requesting more safety data on an experimental new testosterone treatment after a patient developed an allergic reaction and suffered red, itchy bumps on his skin during clinical trials. Antares Pharma Inc., is required to test its drug QuickShot Testosterone (QST) on 70 more patients over six months in order to meet the agency’s 350-patient testing requirement. QST is the only self-administered subcutaneous testosterone treatment currently in late-stage clinical trials. The treatment is considered more favorable than other injectable testosterone drugs, which are intramuscular injections and must be administered by a doctor. Testosterone replacement therapies ... Read More

Sharpton takes credit for Viagra in Rubenstein’s home


The Rev. Al Sharpton has taken responsibility for the little blue erectile dysfunction pill Viagra found in civil rights lawyer Sanford Rubenstein’s apartment. The dug was found while cops were investigating a woman’s claim that Rubenstein raped her after Sharpton’s 60th birthday party. While Rubenstein was later cleared after a three-month investigation, the question still remains, how did Sharpton’s Viagra end up in Rubenstein’s home? Sharpton says he is “unembarrassable” and that the story was a lame attempt to turn the spotlight away from his police brutality message. “Whatever they say, I did it – and more,” he said. “Now ... Read More